hexylresorcinol
Hexylresorcinol is an organic compound with local anaesthetic, antiseptic and anthelmintic properties. It is available for use topically on small skin infections, or as an ingredient in throat lozenges. Hexylresorcinol may be used as a cosmetic biocide. Hexylresorcinol was introduced by Leonard as a urinary antiseptic with great possibilities. Used in alkaline solution it promised success in experiments in vitro. Boots Hexylresorcinol 2.4mg Throat Lozenges, marketed in UK, are used to relieve sore throat pain. Hexylresorcinol has being shown to be useful for the topical treatment of hyperpigmentation. — NCATS
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Earliest trial started Jul 1, 2019 (NCT04345094)
Timeline
No events for the selected filters.
Indications
Approved for
Chemistry & pharmacology
SMILES
CCCCCCC1=C(O)C=C(O)C=C1- Mol. weight
- 194.2701 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHexylresorcinol ↗
- NCATSR9QTB5E82N ↗
- ChEMBLCHEMBL443605 ↗
Also known as
- 4-hexylresorcinol
- antascarin
- ascaricid
- ascarinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- hexylresorcinol
- sucrets
- sucrets
- sucrets
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04345094 | N/A | Jul 1, 2019 | Pacific Skin Institute, Sytheon Ltd. |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pacific Skin Institute | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Sytheon Ltd. | For profit | 1 | 1 | 1 | 2019 |